Khan, Nadia External Author

Publications

Sort by

Selected publications

  • Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell LymphomaClinical Lymphoma, Myeloma and Leukemia2019 Academic Article GET IT
    Times cited: 6
  • Hodgkin lymphoma version 1.2017JNCCN Journal of the National Comprehensive Cancer Network2017 Article GET IT
    Times cited: 39
  • Hodgkin Lymphoma, version 2.2015JNCCN Journal of the National Comprehensive Cancer Network. 2015 Review GET IT
    Times cited: 27